Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $44.33 million. The enterprise value is $38.25 million.
Important Dates
The last earnings date was Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 40.67 million shares outstanding. The number of shares has increased by 79.34% in one year.
| Current Share Class | 40.67M |
| Shares Outstanding | 40.67M |
| Shares Change (YoY) | +79.34% |
| Shares Change (QoQ) | +10.10% |
| Owned by Insiders (%) | 8.90% |
| Owned by Institutions (%) | 28.69% |
| Float | 30.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.32 |
| P/TBV Ratio | 4.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.30, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.30 |
| Quick Ratio | 5.05 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -257.72% and return on invested capital (ROIC) is -141.04%.
| Return on Equity (ROE) | -257.72% |
| Return on Assets (ROA) | -125.28% |
| Return on Invested Capital (ROIC) | -141.04% |
| Return on Capital Employed (ROCE) | -170.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$454,450 |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.08% in the last 52 weeks. The beta is -3.97, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -3.97 |
| 52-Week Price Change | -41.08% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.62 |
| Relative Strength Index (RSI) | 56.55 |
| Average Volume (20 Days) | 116,502 |
Short Selling Information
The latest short interest is 246,294, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 246,294 |
| Short Previous Month | 258,470 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 2.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.39M |
| Pretax Income | -17.47M |
| Net Income | -18.18M |
| EBITDA | -17.51M |
| EBIT | -18.39M |
| Earnings Per Share (EPS) | -$0.54 |
Full Income StatementBalance Sheet
The company has $6.99 million in cash and $914,000 in debt, giving a net cash position of $6.07 million or $0.15 per share.
| Cash & Cash Equivalents | 6.99M |
| Total Debt | 914,000 |
| Net Cash | 6.07M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 10.26M |
| Book Value Per Share | 0.25 |
| Working Capital | 5.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.91 million and capital expenditures -$2.03 million, giving a free cash flow of -$16.94 million.
| Operating Cash Flow | -14.91M |
| Capital Expenditures | -2.03M |
| Free Cash Flow | -16.94M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |